Life ScienceCompany
Immedica Pharma M&A Summary
Immedica Pharma has acquired 1 company of its own, including 1 in the last 5 years.
Immedica Pharma’s largest acquisition to date was in 2024, when it acquired Marinus Pharmaceuticals for $151M. Immedica Pharma has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).
Immedica Pharma Ownership
Who owns Immedica Pharma?
Immedica Pharma is owned by Impilo. It was acquired on July 30, 2018.
Is Immedica Pharma PE-backed?
Yes. Immedica Pharma is owned by private equity investor Impilo.
Immedica Pharma Business Overview
Where is Immedica Pharma headquartered?
Immedica Pharma is headquartered in Stockholm, Sweden.
How many employees does Immedica Pharma have?
Immedica Pharma has 40 employees.
What sector is Immedica Pharma in?
Immedica Pharma is a life science company.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
Unlimited Searches
